Serial analysis of hematological, biochemical, and immunological parameters alterations in regular healthy voluntary donors during plateletpheresis donation.

Autor: Hans R; Department of Transfusion Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Pahwa D; Department of Transfusion Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Paul P; Department of Transfusion Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Kaur J; Department of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Saikia B; Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Sharma RR; Department of Transfusion Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Marwaha N; Department of Transfusion Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Jazyk: angličtina
Zdroj: Asian journal of transfusion science [Asian J Transfus Sci] 2023 Jul-Dec; Vol. 17 (2), pp. 157-163. Date of Electronic Publication: 2023 May 11.
DOI: 10.4103/ajts.ajts_119_22
Abstrakt: Background and Objectives: The long-term effect of regular plateletpheresis on donors has not been characterized. Hence, we planned to study the long-term alterations in hematological, biochemical, and immunological parameters in regular repeat platelet apheresis donors.
Materials and Methods: Thirty-three healthy voluntary regular repeat apheresis donors presenting for platelet donation, fulfilling the requisite donor selection criteria, underwent sequential analysis of the hematological, biochemical, and immunological parameters over 1 year.
Results: A total of 33 regular repeat donors were enrolled in the study; out of these, 22 could be followed up to 3 months, 12 up to 6 months, and 10 donors up to 12 months for their hematological, biochemical, and immunological parameters. Overall, there was no significant change in hematological profile except a rise in platelet count at 3 months ( P = 0.023) with no significant difference at 6 and 12 months from the baseline. In addition, serum thrombopoietin levels at 3 months ( P = 0.010) and serum erythropoietin at 6 months ( P = 0.01) were significantly higher than baseline. Mean platelet volume was significantly higher from baseline at 12 months ( P = 0.00). Serum protein, lymphocyte subpopulation, and serum ferritin did not show any significant change from baseline over 12 months of follow-up. However, there was a significant decline ( P = 0.00) in serum calcium and an increase in serum magnesium from baseline ( P = 0.03) at 12 months.
Interpretations and Conclusions: To conclude, apheresis platelet donation is a safe procedure. However, a complete hematological, biochemical, immunological profile and bone marrow density at regular intervals (3-6 months) are recommended to ensure the safety of regular repeat plateletpheresis donors.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2023 Asian Journal of Transfusion Science.)
Databáze: MEDLINE
Externí odkaz: